347 related articles for article (PubMed ID: 26715915)
21. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone reverses glucocorticoid receptor RNA depression in multi-drug resistant (MDR) myeloma cell lines.
Danel-Moore L; Brönnegard M; Gustafsson JA
Med Oncol Tumor Pharmacother; 1992; 9(4):199-204. PubMed ID: 1342065
[TBL] [Abstract][Full Text] [Related]
24. The mRNA Expression and Regulation of Glucocorticoid Receptor Isoforms Associated with Response of Multiple Myeloma Treated with a Glucocorticoids-Dependent Regimen of Dexamethasone, Bortezomib and Thalidomide.
Guan Y; Si Y; Cai W; Ma L; Fang M
Ann Clin Lab Sci; 2021 Nov; 51(6):805-817. PubMed ID: 34921034
[TBL] [Abstract][Full Text] [Related]
25. Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure.
Boldizsár F; Pálinkás L; Czömpöly T; Bartis D; Németh P; Berki T
Immunobiology; 2006; 211(10):785-96. PubMed ID: 17113916
[TBL] [Abstract][Full Text] [Related]
26. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
27. The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression.
Lynch JT; Rajendran R; Xenaki G; Berrou I; Demonacos C; Krstic-Demonacos M
Mol Cancer; 2010 Feb; 9():38. PubMed ID: 20156337
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells.
Mitre-Aguilar IB; Barrios-Garcia T; Ruiz-Lopez VM; Cabrera-Quintero AJ; Mejia-Dominguez NR; Ventura-Gallegos JL; Moreno-Mitre D; Aranda-Gutierrez A; Mejia-Rangel J; Escalona-Guzman AR; Chavarri-Guerra Y; Leon-Del-Rio A; Zentella-Dehesa A
BMC Cancer; 2019 Apr; 19(1):356. PubMed ID: 30987626
[TBL] [Abstract][Full Text] [Related]
29. Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis.
Yan H; Frost P; Shi Y; Hoang B; Sharma S; Fisher M; Gera J; Lichtenstein A
Cancer Res; 2006 Feb; 66(4):2305-13. PubMed ID: 16489035
[TBL] [Abstract][Full Text] [Related]
30. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.
Spokoini R; Kfir-Erenfeld S; Yefenof E; Sionov RV
Mol Endocrinol; 2010 Jun; 24(6):1136-50. PubMed ID: 20371704
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
West DC; Kocherginsky M; Tonsing-Carter EY; Dolcen DN; Hosfield DJ; Lastra RR; Sinnwell JP; Thompson KJ; Bowie KR; Harkless RV; Skor MN; Pierce CF; Styke SC; Kim CR; de Wet L; Greene GL; Boughey JC; Goetz MP; Kalari KR; Wang L; Fleming GF; Györffy B; Conzen SD
Clin Cancer Res; 2018 Jul; 24(14):3433-3446. PubMed ID: 29636357
[No Abstract] [Full Text] [Related]
32. Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors.
Sharma S; Lichtenstein A
Blood; 2008 Aug; 112(4):1338-45. PubMed ID: 18515658
[TBL] [Abstract][Full Text] [Related]
33. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma.
Yang M; Shen JK; Huang J; Du HP; Ma QL; Jin J
Leuk Lymphoma; 2009 May; 50(5):802-8. PubMed ID: 19330649
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid receptor in multiple myeloma.
Murakami T; Togawa A; Satch H; Katoh M; Imamura Y; Ohsawa N; Takaku F
Eur J Haematol; 1987 Jul; 39(1):54-9. PubMed ID: 3653372
[TBL] [Abstract][Full Text] [Related]
36. Effect of EPA on Hsp90 and GRα protein expression in multiple myeloma drug-resistant cells.
Wu S; Chen Y; Wang X; Weng S; Zhou W; Liu Z
BMC Cancer; 2021 Oct; 21(1):1076. PubMed ID: 34600510
[TBL] [Abstract][Full Text] [Related]
37. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma.
Wang W; Hayashi J; Serrero G
Clin Cancer Res; 2006 Jan; 12(1):49-56. PubMed ID: 16397023
[TBL] [Abstract][Full Text] [Related]
38. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford HL; Munshi NC; Anderson KC
Br J Haematol; 2006 Oct; 135(1):52-61. PubMed ID: 16925573
[TBL] [Abstract][Full Text] [Related]
39. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA
Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes.
Reichardt SD; Föller M; Rexhepaj R; Pathare G; Minnich K; Tuckermann JP; Lang F; Reichardt HM
Endocrinology; 2012 Apr; 153(4):1783-94. PubMed ID: 22294744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
